In addition, USP30 depletion enhances CCCP- and BH3 mimetic-induced cell death.64 This indicates that USP30 inhibition, in addition to promoting mitophagy in neurodegeneration, may potentially serve as a target for cancer therapy. This evidence concerns the gene USP30 and cancer.